Asset Details
Do you wish to reserve the book?
Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
Do you wish to request the book?
Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
2018
Overview
The immune system has been traditionally divided into two arms called innate and adaptive immunity. Typically, innate immunity refers to rapid defense mechanisms that set in motion within minutes to hours following an insult. Conversely, the adaptive immune response emerges after several days and relies on the innate immune response for its initiation and subsequent outcome. However, the recent discovery of immune cells displaying merged properties indicates that this distinction is not mutually exclusive. These populations that span the innate-adaptive border of immunity comprise, among others, CD1d-restricted natural killer T cells and MR1-restricted mucosal-associated invariant T cells. These cells have the unique ability to swiftly activate in response to non-peptidic antigens through their T cell receptor and/or to activating cytokines in order to modulate many aspects of the immune response. Despite they recirculate all through the body
the bloodstream, these cells mainly establish residency at barrier sites including lungs. Here, we discuss the current knowledge into the biology of these cells during lung (viral and bacterial) infections including activation mechanisms and functions. We also discuss future strategies targeting these cell types to optimize immune responses against respiratory pathogens.
Publisher
Frontiers Media SA,Frontiers,Frontiers Media S.A
Subject
/ Animals
/ bacteria
/ Histocompatibility Antigens Class I - analysis
/ Humans
/ Lipids
/ lung
/ Minor Histocompatibility Antigens - analysis
/ Mucosa
/ mucosal-associated invariant T cells
/ Mucosal-Associated Invariant T Cells - immunology
/ Natural Killer T-Cells - immunology
/ Pneumonia, Bacterial - immunology
/ Pneumonia, Viral - immunology
